The use of heparin for acute ischaemic stroke has long been controversial. Although it may have some theoretical benefits in preventing fibrin formation and thrombus propagation, data from 16 randomised controlled trials involving more than 22,000 patients show that heparin produces no significant net benefit in eventual outcome.
|Number of pages||3|
|Journal||Medical Journal of Australia|
|Publication status||Published - 16 Nov 1998|